Editorial Policies

Focus and Scope

Journal of Pediatric Diseases (JPedD) is an international peer-reviewed open access journal. It publishes papers on health and medical care of infants, children and adolescents. The Journal accepts high quality submissions presented as Original Research Articles, Review Articles, Short Communications, Case Reports, Mini- Reviews, Opinions, and Letters to the Editor, in all areas of pediatric research. Through a meticulous process of peer review, the Journal of Pediatric Diseases strives to publish pediatric research with the highest value for pediatric healthcare professionals.

As an open access journal, Journal of Pediatric Diseases is committed to provide maximum accessibility to accepted articles, and consequently help the authors achieve the highest possible citations.

The scopes of the journal include but are not limited to

  • General Pediatrics
  • Pediatric Infectious Diseases
  • Tropical Pediatric Diseases
  • Pediatric Medicines and Drug Development
  • Ethics in Pediatric Disease Research
  • History of Pediatric Diseases
  • Pediatric Allergy and Autoimmune Diseases
  • Pediatric Vaccination
  • Pediatric Intensive Care
  • Pediatric Orthopedic
  • Pediatric Cardiology
  • Pediatric Oncology
  • Pediatric Endocrinology
  • Pediatric Psychiatry
  • Pediatric Surgery
  • Pediatric Urology and Nephrology
  • Pediatric Dentistry
  • Pediatric Nursing Care
  • Pediatric Imaging
  • Pediatric Neuroscience
  • Pediatric Hematology

 

Section Policies

 

Peer Review Process

All manuscripts submitted to the Journal of Pediatric Diseases are subjected to a stringent peer review process. This is to uphold the high quality of papers published in this journal and ensure that the reporting of research work is truthful and precise.

  1. All submitted manuscript are firstly handled by our managing editor, who will check the manuscript for plagiarism, in which rejection of the manuscript can take place at this stage by the managing editor if plagiarism occurs in the manuscript.
  2. After the plagiarism check is completed and results are deemed satisfactory, the managing editor will pass the manuscript to the Editor-in-Chief who will undertake the peer review process, or at times pass the task to one of the Associate Editors.
  3. A minimum of 2 reviewers will be selected from the pool of reviewers available according to their expertise and suitability to the subject matter of the manuscript. Reviewers will have to give their comments and recommendations (Accept, Revisions Required, Resubmit for Review or Reject) to the Editor-in-Chief or Associate Editor for them to make a final decision on the paper, and their comments will help the authors improve their papers.
  4. Upon recommendations by the reviewers, the Editor-in-Chief or the Associate Editor can make a final decision on the paper and inform the author on their decision, adding comments to the Authors to make improvements in their research or paper.
    • If the decision is to Accept Submission (no amendments required by author), the manuscript will be sent to the Editing stage.
    • If Editor-in-Chief suggests Revisions Required (minor revisions), authors are given a maximum of 2 weeks to revise and resubmit the article.
    • If Editor-in-Chief suggests Resubmit for Review (major revisions), authors are given a maximum of 4 weeks to revise and resubmit the article for the second round of review.
    • If the decision is to Reject Submission, the author will be notified and the rejected manuscript will be archived and the peer review process ends.
  5. An accepted paper will be sent for Copy Editing, Layout Editing and Proofreading before publication. Correspondence between the authors and editors will be required here in order to improve the language and/or look of the manuscript. After the Editing stage is completed, authors are required to check the PDF file of the final version before the article is published. EnPress Publisher registers DOI for the manuscript after publication, in which the article is immediately accessible to the public.
  6. Authors may appeal for a rejected submission. Appeal requests must be made in writing to contact@enpress-publisher.com with detailed reasons for the appeal and point by point responses to the reviewers’ remarks. Decisions on appeals are final and no further consideration will be made.

 

Open Access Policy

This journal provides immediate Open Access to its content as it believes that making research freely available to the public which helps promoting the research results benefiting the scholarly community.

  • Higher Visibility, Availability and Citations – free and unlimited accessibility of the publication over the internet without any restrictions increases citation of the article
  • Ease of search – publications are easily searchable in search engines and indexing databases
  • Rapid Publication – accepted papers are immediately published online

 

Editorial Policies

A manuscript would not be accepted if it has been published or is under consideration for publication in any other journal. The author also needs to notify the journal if the data presented in this paper has been ever presented in conferences.

 

Authorship

Authorship of a scholarly paper should be limited to individuals who have contributed substantially to its intellectual content. Participation solely in the acquisition of funding or general supervision of the research group is not sufficient for authorship. All authors should hold the responsibility of fairly evaluating their respective roles and their co-authors’ roles in the project. This is to ensure that authorship is attributed according to a fixed standard in all publications for which they will be listed as authors.

In order to be listed as an author for a paper, one should have contributed sufficiently in the project. A co-author is expected to have contributed to some component of the work which led to the paper, or be involved in interpretation of its results. All authors should have a say in the final approval of the version to be published, in addition to reviewing the final manuscript prior to submission.

Individuals who do not meet the above requirements, but have provided a valuable contribution to the work, may be acknowledged for their contribution as appropriate to the publication.

 

Conflict of Interest

Conflicts of interest may exist when professional judgements concerning a primary interest has the possibility of being influenced by a secondary interest (e.g.: financial gains). It is to be noted that even perceptions of conflicts of interest are as important as the actual conflicts of interest.

Any agreements with study sponsors (for profit or non-profit), which interfere with the authors’ access to the study data, ability to analyse or interpret the data and publish manuscripts independently according to their own decision, should be avoided by authors at all costs.

A declaration of interests for all authors must be received before an article can be reviewed and accepted for publication.

 

Plagiarism

Authors are advised to perceive high standards in the aspect of publication ethics. Any plagiarism (fabrication or falsification of data) are strictly unacceptable practices in Trends in Immunotherapy, including duplicate publication of the author’s work without proper citation.

Every manuscript submitted for publication is checked for plagiarism via CrossCheck (powered by iThenticate) after submission and before being sent to the editor for editorial review. Any detection of overlapping and similar texts in the manuscripts submitted will be investigated promptly and may lead to the manuscript being rejected.

 

Language

The language used in manuscripts submitted to Journal of Pediatric Diseases is English. Authors whose first language is not English may want to have their manuscripts professionally edited before the final submission to ensure that the academic content of the paper is fully understood by its prospective readers.

 

Permission and Reprints

Any part of materials published in Journal of Pediatric Diseases may not be reproduced without written permission of the publisher. Please click here to write in the permission request.

 

Publishing Ethics

This journal requests all members involved in the journal publishing process to adhere to the Core Practices on publication ethics as stipulated by Committee on Publication Ethics (COPE) in compliance with the information and guidelines on handling publishing ethics allegations as described in the Publishing Ethics Resource Kit (PERK).

The journal editors take all possible misconducts seriously. The Editors, authors or readers can forward their concerns to the journal if they find out that the description in a submitted article may constitute an academic fraud, research misconduct or publication malpractice. The concerns or complaints on the possible allegations submitted to the journal will be dealt with promptly and appropriately according to the procedure set out in the COPE flowchart on complaints and in PERK. The complainant may direct all inquiries and correspondence to the Publisher at editor@enpress.com.

This journal adopts a zero-tolerance policy concerning any academic misconducts and ethical violations in research and publication regardless of the severity of these issues. The violations include plagiarism, falsification of research, data fabrication, submitting manuscripts of others as one’s own, submission of same manuscript to different publication venues at the same time and breached intellectual property rights. In cases of suspected misconduct and ethical violation, a panel will be formed to investigate the allegation. If the allegation is supported by evidence, the submitted manuscript in question will be declined for consideration in the journal and all authors will be informed in this regard. A retraction initiated by authors or by the journal is required to take place if the paper has already been published, and the retraction will be made public. Authors of the work in question will receive the Panel’s Decision via email and all appeals regarding the decision will have to be made to the Publisher at editor@enpress.com within 28 days of the decision date.

 

Changes to Authorship

The authors should carefully check the list and order of authors before submitting their manuscript. The Editorial Office considers the authorship list is definitive by the time the original submission is received.

Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript is accepted for publication. The corresponding author should provide the reasons for the change in authorship list and the proof of written confirmation from all authors (including the existing authors, author(s) to be added and/or removed) agreeing with such change, to the Editorial Office.

The requests for authorship changes need to be approved by the Editorial Office before any changes can be made.

 

Withdrawal Policy

If you decide to withdrawal your manuscript after it has been accepted (but not yet published), a processing fee of USD 200 is chargeable upon withdrawal.

 

Disclaimer

This journal  is not liable to the statements, perspectives, and opinions contained in the published articles. The appearance of advertisements in the journal shall not be construed as a warranty, endorsement, or approval of the products or services advertised and/or the safety thereof. This journal and the Publisher disclaim responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.

 

Copyright and License

The authors shall retain the copyright of their work but allow the Publisher to publish, copy, distribute, and convey the work.

All articles published by the Journal of Pediatric Diseases are licensed under the Creative Commons International Licenses. Without any explicit request from the corresponding author during submission stage, a paper will be published under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) by default. The authors who would like to publish their work under a more accommodating license, i.e. Creative Commons Attribution 4.0 International License (CC BY 4.0), they should express explicit request during submission stage. Please include statement below in the Comments for the Editor column on the submission page:

The contributors or authors for this submission entitled “[MANUSCRIPT TITLE]”, i.e. [NAMES of ALL AUTHORS], have given their consents to alter the Creative Commons license to *CC BY 4.0* under which this submission will be published in Journal of Pediatric Diseases.

 

Advertising Policy

All advertisements are subject to approval to the Publisher. Advertisements must comply with the relevant regulations in the country where the advertisements appear. For more inquiries, please send email to editor@enpress.com.

 

Publication Frequency

bi-annual

 

Human Research

If human subjects were used in the experiments, authors must identify the committee or organization (e.g. author’s Institutional Ethics Review Board) approving the experiments in the Methodology section of the manuscript, which should also detail ethics approval information such as the name of the granting committee or organization and the approval identifiers, i.e. reference numbers. This journalrequires that authors provide a proof of research ethics or ethics statement along with the submission. In the case that ethics approval identifiers are not available, written approval from the granting committee or organization must be provided as confidential supplemental file.

In the manuscript, include a statement in the Methodology section confirming that the experiments were carried out in adherence to the ethical principles set out in the WMA Declaration of Helsinki and that informed consent was obtained from all human subjects. 

For investigations undertaken on human subjects, the manner in which the informed consent was obtained from the study participants (i.e., oral or written) should be stated clearly as well.

The authors should inform the study participants of the purpose(s) of publication, the possible risks and benefits as a result of the experiment, and the patient's right to withhold or withdraw consent. Consent should be obtained from the parent(s) or legal guardian(s) if the study participant is a minor.

Authors are obliged to declare and clearly specify any restrictions on the availability or the use of human data in the manuscript.

Authors are encouraged to follow the CARE guidelines while reporting a clinical case that involves the use bioprinted construct on human subject. If the article reporting guidelines suggested by the Journal of Pediatric Diseases were not pertinent to your work, please look for and refer to the appropriate reporting standards as found on EQUATOR Network, which have been adopted by the field of the works or which apply to their study design.

 

Patient Anonymity and Privacy

Human subjects have a right to privacy that should not be violated without informed consent. Identifying information or patient identifiers, including patient names, initials, date of birth, contacts, medical record numbers, hospital numbers, and geographical location, should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Efforts must be made by the authors to at least mask or conceal any identifying information of the patients that appear in writing or within photograph.

Authors are obliged to explain to the patient if revealing the patient’s identity cannot be fully avoided, e.g. an image of an identifiable body part like the face has to be published in the report. The relevant identifying information to be published, e.g. the image, must be shown to the patient, and consent for publication taken for the use of that information in the publication. If the patient dies, then consent must be obtained from next of kin or legal representative. Authors may consider using our sample Consent Form for Publication in the Journal of Pediatric Diseases. This journal  shall consider author version of consent form for publication if all the essential items as shown in our sample consent form were included.

All submissions will be checked for documentation of patient consent for publication and for any potentially identifying information. Submissions that include identifying patient information without appropriate patient consent will not be considered for publication.

Refer to ICMJE Privacy and Confidentiality guidelines for more information about patient anonymity and privacy.

 

Animal Research

For studies reporting experiments that involve testing on regulated animals (i.e. all live vertebrates and/or higher invertebrates), authors must identify the committee or organization (e.g. author’s Institutional Ethics Review Board) approving the experiments in the Methodology section of the manuscript, which should also detail ethics approval information such as the name of the granting committee or organization and the approval identifiers, i.e. reference numbers. For research conducted on non-regulated animals, a statement should be made as to why ethical approval was not required.

This journal requires that authors provide a proof of research ethics or ethics statement along with the submission. In the case that ethics approval identifiers are not available, written approval from the granting committee or organization must be provided as confidential supplementary file.

Authors are encouraged to follow the ARRIVE guidelines while reporting animal research. In the manuscripts, any additional guidelines for the care and use of laboratory animals that were used in the experiment should be indicated. Briefly, the authors should also include animal details (e.g. species, gender, age, weight), animal housing conditions and husbandry information, and relevant steps taken to ameliorate pain and suffering of the animals in the Methodology section.

Specifically, experiments on non-human primates must be performed in accordance with the recommendations set out in the Weatherall report (The Use of Non-Human Primates in Research).

 

 

Indexing

Journal of Pediatric Diseases is indexed, cataloged and/or included by several world-class abstracting/indexing databases:

 CNKI Scholar (中国知网)

Crossref

Google Scholar

National Library Board of Singapore

Scilit

Worldcat 

 

Article Processing Charges (APC)

Enpress publishes all its journals in Gold Open Access format. The scientific community and the general public have free of all restrictions on accessing (e.g., subscription) and free of many restrictions on using its contents as soon as it is published online. Enpress does not require readers to purchase any form of subscription to view online versions of the journals. In order to defray our editorial and production costs, authors of the accepted articles are required to pay the article processing charges (APCs). The charges will come from authors' institutes or research funding bodies.

Journal

APC

Journal of Pediatric Diseases

 

US $800








contact us

14701 Myford Road, Suite B-1, Tustin, CA 92780, United States
Tel:+1 (949) 299 0192